Article Information
History
- May 1, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Christine M. Lovly, M.D., Ph.D.*,
- Kelli L. Boyd, D.V.M., Ph.D.,
- Paula I. Gonzalez-Ericsson, M.D.,
- Cindy L. Lowe, B.S.,
- Hunter M. Brown, M.S.,
- Robert D. Hoffman, M.D., Ph.D.,
- Brent C. Sterling, M.D.,
- Meghan E. Kapp, M.D., M.S.,
- Douglas B. Johnson, M.D., M.S.C.I.,
- Prasad R. Kopparapu, Ph.D.,
- Wade T. Iams, M.D.,
- Melissa A. Warren, M.D.,
- Michael J. Noto, M.D., Ph.D.,
- Brian I. Rini, M.D.,
- Madan Jagasia, M.B.B.S., M.S.,
- Suman R. Das, Ph.D. and
- Justin M. Balko, Pharm.D., Ph.D.
- Departments of Medicine Pathology, Microbiology, and Immunology and Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville; TN
- ↵*Corresponding author: Christine M. Lovly, M.D., Ph.D., 2220 Pierce Avenue, 777 Preston Research Building, Nashville, TN 37232-6307, Phone: 615-936-3457, E-mail: christine.lovly{at}vumc.org
Author Contributions: C.M.L., K.L.B., and J.M.B. conceived and designed the study. C.M.L., K.L.B., C.L.L., H.M.B., P.I.G-E, P.R.K., S.R.D., D.B.J., D.B.J., and J.M.B. acquired, analyzed, and/or interpreted the data. C.M.L., R.D.H., B.C.S., M.E.K., W.T.I., M.A.W., M.J.N., and M.J. performed clinical or post-mortem care of the patient. C.M.L. wrote the manuscript. All authors reviewed the manuscript.
Posted May 01, 2020.
Rapidly fatal pneumonitis from immunotherapy and concurrent SARS-CoV-2 infection in a patient with newly diagnosed lung cancer
